3D genome mapping in rare immune cells reveals new Crohn’s genes
Cancer cells hijack a fatty acid to escape immune attack in liver metastases
Collaboration aims to develop new class of medicines for in vivo CAR-T
Data validates new method for single-cell transcriptomic tumour profiling from clinical pathology samples
Smart mRNA drugs that listen to the body
New insights into genome ejection from AAV vectors
New drug for diabetes and obesity shows promising results
Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
New nanoparticles offer safer, more effective drug delivery
Two key proteins perform powerful functions on a major secretory pathway
RyboDyn joins Lilly Gateway Labs to advance next-gen immunotherapies
Study reveals processes important for skin cancer aggressiveness and identifies two classes of drugs that may block them